Clinical Trials Directory

Trials / Completed

CompletedNCT05031650

Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room

Can Open Lung Strategy During Non-Invasive Respiratory Support of Very Premature Infants in the Delivery Room Reduce Non-Invasive Ventilation Failure Compared With Standard Approach? A Randomised Controlled Multicentric Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
145 (actual)
Sponsor
Dokuz Eylul University · Academic / Other
Sex
All
Age
1 Minute – 2 Minutes
Healthy volunteers
Not accepted

Summary

The opening and aeration of the lung is critical for a successful transition from fetal to neonatal life. Early nasal CPAP in the delivery room in spontaneously breathing premature babies with a gestational age of 30 weeks or less is a standard treatment approach since it reduces the need for invasive mechanical ventilation and surfactant therapy. In respiratory distress syndrome (RDS) management, providing optimal lung volumes in the very early period from the beginning of delivery room approaches probably augments the expected lung protective effect. Although the benefits of CPAP support are well known, standart CPAP pressures recommended in the guidelines may not meet the needs of individual babies. Maintaining lung patency in the delivery room is the main mechanism of action of CPAP and the requirement may vary individually depending on lung physiology. In this multicenter randomized controlled study, we aimed to compare the effects of CPAP therapy applied with a personalized open lung strategy (openCPAP), and standard CPAP therapy (standardCPAP) on oxygenation, respiratory support need and surfactant treatment requirement in preterm babies with RDS in the delivery room.

Conditions

Interventions

TypeNameDescription
PROCEDUREopenCPAPRandomized to : Individualized high level CPAP between 8-10 cmH2O pressure
PROCEDUREstandardCPAPRandomized to : Standard level CPAP between 6-8 cmH2O pressure

Timeline

Start date
2019-07-01
Primary completion
2022-12-31
Completion
2023-03-01
First posted
2021-09-02
Last updated
2023-05-10

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05031650. Inclusion in this directory is not an endorsement.